A network view of disease and compound screening

Eric E. Schadt, Stephen H. Friend, David A. Shaywitz

Research output: Contribution to journalArticlepeer-review

248 Scopus citations


The large-scale generation and integration of genomic, proteomic, signalling and metabolomic data are increasingly allowing the construction of complex networks that provide a new framework for understanding the molecular basis of physiological or pathophysiological states. Network-based drug discovery aims to harness this knowledge to investigate and understand the impact of interventions, such as candidate drugs, on the molecular networks that define these states. In this article, we describe how such an approach offers a novel way to understand biology, characterize disease and ultimately develop improved therapies, and discuss the challenges to realizing these goals.

Original languageEnglish
Pages (from-to)286-295
Number of pages10
JournalNature Reviews Drug Discovery
Issue number4
StatePublished - 2009
Externally publishedYes


Dive into the research topics of 'A network view of disease and compound screening'. Together they form a unique fingerprint.

Cite this